Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Presentation EuroPCR 2025

Angiography versus physiology-guided PCI in patients undergoing TAVI: the functional assessment in TAVI (FAITAVI) trial

Presenter: Flavio Ribichini

May 22, 2025

Presentation EuroPCR 2024

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Presenter: Ole De Backer

May 15, 2024

Presentation EuroPCR 2024

Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

Presenter: Patrick Serruys

May 15, 2024

Presentation EuroPCR 2024

Using temporary permanent pacemaker as a one-month bridge after TAVI

Presenter: Guangyuan Song

May 14, 2024

Presentation EuroPCR 2024

Small aortic annuli patients treated with TAVI: outcomes in women in the SMART trial

Presenter: Roxana Mehran

May 14, 2024

Presentation EuroPCR 2024

Impact of valve type and anaesthesia strategy for TAVI – 5-year results of the SOLVE-TAVI trial

Presenter: Hans-Josef Feistritzer

May 14, 2024

Presentation EuroPCR 2023

BENCHMARK: A streamlined TAVI pathway with uncompromised safety in 28 European centres

Presenter: Derk Frank

May 17, 2023

Presentation EuroPCR 2019

Ten year follow-up of patients treated with transcatheter aortic valve implantation

Presenter: Janarthanan Sathananthan

May 21, 2019

Presentation EuroPCR 2019

Impact of Renin-Angiotensin System inhibition in patients following Transcatheter Aortic Valve Implantation: The multicenter RASTAVI study.

Presenter: IJ. Amat-Santos

May 21, 2019

Presentation EuroPCR 2019

Five-year outcomes after TAVI with balloon-expandable vs. self-expanding valves: Results from the CHOICE randomised clinical trial

Presenter: Mohamed Abdel-Wahab

May 21, 2019

Presentation EuroPCR 2017

Prosthesis-Related Events and Echocardiographic Data Throughout 9 Years Follow Up After TAVI

Presenter: Luca Testa

May 19, 2017

Presentation EuroPCR 2012

30 Day Outcomes from the SOURCE XT TAVI Post Approval Study

Presenter: 203692|Olaf Wendler

May 18, 2012

Advertisement

Angiography versus physiology-guided PCI in patients undergoing TAVI: the functional assessment in TAVI (FAITAVI) trial

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

Using temporary permanent pacemaker as a one-month bridge after TAVI

Small aortic annuli patients treated with TAVI: outcomes in women in the SMART trial

Impact of valve type and anaesthesia strategy for TAVI – 5-year results of the SOLVE-TAVI trial

BENCHMARK: A streamlined TAVI pathway with uncompromised safety in 28 European centres

Ten year follow-up of patients treated with transcatheter aortic valve implantation

Impact of Renin-Angiotensin System inhibition in patients following Transcatheter Aortic Valve Implantation: The multicenter RASTAVI study.

Five-year outcomes after TAVI with balloon-expandable vs. self-expanding valves: Results from the CHOICE randomised clinical trial

Prosthesis-Related Events and Echocardiographic Data Throughout 9 Years Follow Up After TAVI

30 Day Outcomes from the SOURCE XT TAVI Post Approval Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content